What is COCH's earnings growth forecast for 2026-2026?
(NASDAQ: COCH) Envoy Medical's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Envoy Medical's earnings in 2026 is -$28,611,000.
In 2026, COCH is forecast to generate -$34,647,445 in earnings, with the lowest earnings forecast at -$33,288,721 and the highest earnings forecast at -$35,666,487.
What is COCH's revenue growth forecast for 2026-2026?
(NASDAQ: COCH) Envoy Medical's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Envoy Medical's revenue in 2026 is $208,000.
In 2026, COCH is forecast to generate $7,340,560 in revenue, with the lowest revenue forecast at $5,642,156 and the highest revenue forecast at $9,067,751.
What is COCH's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: COCH) forecast ROA is -423.51%, which is lower than the forecast US Medical Devices industry average of 10.02%.
What is COCH's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: COCH) Envoy Medical's current Earnings Per Share (EPS) is -$1.42. In 2026, COCH's EPS is forecast to hit -$1.20 (min: -$1.16, max: -$1.24).
What is COCH's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: COCH) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.